V.HasnainS
FIGURE 1 Results and Discussion Oral Semaglutide Has Great Potential for the Prevention of Retinal Neurodegeneration There is a demonstrated neuroprotective effect of GLP-1R agonists in both the retina and brain in preclinical studies of ocular hypertension, diabetic retinopathy, Alzheimers disease, Parkinsons disease, stroke, neuropathy, and several other neurodegenerative diseases (Kastin et al., 2002
Real-world signals
They mimic a natural hormone your body already produces one that helps control appetite, blood sugar, and digestion
Retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors, distinguishing it from dual agonists such as tirzepatide
Tirzepatide behaves differently from the single-target GLP-1 agonists, and that difference is worth understanding before you pair it with any telehealth program